Hyloris reports full year results for 2022 & provides
Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing dealsPotential U.S. market approval for...
Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing dealsPotential U.S. market approval for...
Ageas initiated exclusive negotiations for the disposal of its French activities Ageas has entered into exclusive negotiations with La Mutuelle Epargne...
The company’s cash is held at banks with a Moody’s rating of A1 or higher...
NEWS RELEASE – REGULATED INFORMATION MARCH 3, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – March 3, 2023 – MDxHealth SA (Nasdaq and...
Solvay to sell its stake in RusVinyl Brussels, March 3, 2023 - 17:45 CET Solvay announced that it has agreed on final terms to sell its 50% stake in...
Solvay highlights innovation and growth opportunities in Aerospace & Defense market The Group held a webinar focused on activities in its Composite...
The company has now been awarded a total of eight FDA Breakthrough Device Designations for its innovative SCI therapies...
23 February 2023, 7:00am, Antwerp, Belgium: VGP NV (‘VGP’ or ‘the Group’), today announces the results for the financial year ended 31 December 2022: ...
Publication on February 17, 2023, before market openingRegulated information – Press release annual resultsEVS Broadcast Equipment S.A.: Euronext Brussels...
2022 EPRA earnings: € 45,4 million, an increase of 1% compared to 2021EPRA earnings per share: € 1,71, a decrease of 2% compared to 2021Proposed...
Email: info@10toptenreviews.com
10 Top Ten Reviews is part of VSG Solution JSC, an international media group and leading digital publisher.
© 2021 - 10TopTenReiews All Rights Reserved.